A Polarity-Sensitive Far-Red Fluorescent Probe for Glucose Sensing through Skin
Biosensors · 2023
DOI: 10.3390/bios13080788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2023. Verfasst von Lydia Colvin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Texas A&M University, College Station, TX 77843, USA. Hauptthemen laut MEDLINE: Fluorescent Dyes, Quinolines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation, Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, NSF Engineering Research Center: Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP).
Abstract (Originalsprache)
The field of glucose biosensors for diabetes management has been of great interest over the past 60 years. Continuous glucose monitoring (CGM) is important to continuously track the glucose level to provide better management of the disease. Concanavalin A (ConA) can reversibly bind to glucose and mannose molecules and form a glucose biosensor via competitive binding. Here, we developed a glucose biosensor using ConA and a fluorescent probe, which generated a fluorescent intensity change based on solvatochromism, the reversible change in the emission spectrum dependent on the polarity of the solvent. The direction in which the wavelength shifts as the solvent polarity increases can be defined as positive (red-shift), negative (blue-shift), or a combination of the two, referred to as reverse. To translate this biosensor to a subcutaneously implanted format, Cyanine 5.5 (Cy5.5)-labeled small mannose molecules were used, which allows for the far-red excitation wavelength range to increase the skin penetration depth of the light source and returned emission. Three Cy5.5-labeled small mannose molecules were synthesized and compared when used as the competing ligand in the competitive binding biosensor. We explored the polarity-sensitive nature of the competing ligands and examined the biosensor’s glucose response. Cy5.5-mannotetraose performed best as a biosensor, allowing for the detection of glucose from 25 to 400 mg/dL. Thus, this assay is responsive to glucose within the physiologic range when its concentration is increased to levels needed for an implantable design. The biosensor response is not statistically different when placed under different skin pigmentations when comparing the percent increase in fluorescence intensity. This shows the ability of the biosensor to produce a repeatable signal across the physiologic range for subcutaneous glucose monitoring under various skin tones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Texas A&M University, College Station, TX 77843, USA.
- Center for Remote Health Technologies and Systems, Texas A&M Engineering Experiment Station, College Station, TX 77843, USA.
ORCID-Profile: Dandan Tu, Gerard Coté
Förderung
- National Science Foundation
- Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
- NSF Engineering Research Center: Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP)
Zitieren
APA
Colvin, L., Tu, D., Dunlap, D., Rios, A., & Coté, G. (2023). A Polarity-Sensitive Far-Red Fluorescent Probe for Glucose Sensing through Skin. Biosensors. https://doi.org/10.3390/bios13080788
Vancouver
Colvin L, Tu D, Dunlap D, Rios A, Coté G. A Polarity-Sensitive Far-Red Fluorescent Probe for Glucose Sensing through Skin. Biosensors. 2023. doi:10.3390/bios13080788
BibTeX
@article{Colvin2023,
author = {Colvin, Lydia and Tu, Dandan and Dunlap, Darin and Rios, Alberto and Coté, Gerard},
title = {A Polarity-Sensitive Far-Red Fluorescent Probe for Glucose Sensing through Skin},
journal = {Biosensors},
year = {2023},
doi = {10.3390/bios13080788}
}
EUVIMED